Owner Novartis AG

Inventors Ofner, Silvio; Gasparini, Fabrizio; Zimmermann, Kaspar; Hart, Terance W; Auberson, Yves

Agent Davies Collison Cave

Pub. Number AU-B-2002358585

PCT Number PCT/EP02/13670

PCT Pub. Number WO2003/047581

Priority 0128996.6 04.12.01 GB

Filing date 3 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 19 January 2006

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/404 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 233/23 (2006.01) Carboxylic acid amides

C07C 271/16 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 271/24 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/32 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom